Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of Lianxiaxiaopi Keli for functional dyspepsia
ChiCTR2100041993Phase 2Recruiting
- Sponsor
- Hospital of Chengdu University of Traditional Chinese Medicine
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in functional dyspepsia (FD) comparing Experimental group: Lianxiaxiaopi Keli with Control group: placebo (2 arms). Primary endpoints: Response rate of dyspepsia symptoms, Response rate of postprandial distress syndrome and 4 more. Started Oct 2020; status: recruiting.
02
Drugs
Lianxia Xiaopi Granules
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on ChiCTR2100041993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100041993.